Reveleer

company

About

Reveleer is a SaaS platform solution for clinical data collection and analytics.

  • 51 - 100

Details

Last Funding Type
Series A
Last Funding Money Raised
$2.50M
Industries
Health Care,Information Technology,SaaS,Software
Founded date
Jan 1, 2009
Number Of Employee
51 - 100
Operating Status
Active

Reveleer is a healthcare software and services company that empowers payers in all lines of business to take control over their risk adjustment and quality improvement programs. The Reveleer platform enables payers to independently execute and manage every aspect of provider outreach, retrieval, coding, abstraction and reporting – all under one single platform. Leveraging its technology, proprietary data sets, and subject matter expertise, Reveleer also assists payers with full record retrieval and review services to support financial performance and improved member outcomes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$76.90M
Reveleer has raised a total of $76.90M in funding over 2 rounds. Their latest funding was raised on Dec 7, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 7, 2021 Series Unknown $65M 1 Oak HC/FT Detail
Nov 1, 2016 Series A $3M 1 Detail
Jun 1, 2016 Series A $3M 1 Detail
Jun 1, 2016 Series A $2M 1 Detail
May 20, 2014 Series A $1.40M 1 Detail

Investments

Number of Investments
Number of Lead Investments
3
0
Reveleer has made 3 investments. Their most recent investment was on Oct 31, 2016, when Encore Musicians raised £560K.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 31, 2016 Encore Musicians
Seed £560K Communities
Aug 1, 2015 Encore Musicians
Pre-seed £150K Communities
Jun 17, 2013 Oculus
Series A $16M Augmented Reality

Investors

Number of Lead Investors
Number of Investors
1
2
Reveleer is funded by 2 investors. Oak HC/FT and Redhills Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Oak HC/FT Yes Series Unknown
Redhills Ventures Series A